(Reuters) – The U.S. Food and Drug Administration on Tuesday amended the fact sheet of Johnson & Johnson’s COVID-19 vaccine to include a rare risk of immune thrombocytopenia, a bleeding disorder.
(Reporting by Leroy Leo; Editing by Shailesh Kuber)
U.S. FDA amends J&J vaccine fact sheet to include rare immune bleeding risk
Jan 11, 2022 | 2:38 PM
